Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 94

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 94
---
 |             |          — |
|                            |     | Continuation of Benefits          |     |                  | — |     |                 |          — |     |                  |            — |     |             |          — |
|                            |     | Market Value of Stock Vesting(10) |     |                  | — |     |                 |          — |     |                  | 1,736,018(8) |     |             |          — |
|                            |     | Total                             |     |                  | — |     |                 |    846,068 |     |                  |    2,582,085 |     |             |          — |
| Tsveta Milanova            |     | Severance Payments                |     |                  | — |     |                 | 525,300(1) |     |                  |   525,300(1) |     |             |          — |
|                            |     | Bonus Payment                     |     |                  | — |     |                 | 236,385(3) |     |                  |   236,385(3) |     |             |          — |
|                            |     | Continuation of Benefits          |     |                  | — |     |                 |  17,700(5) |     |                  |    17,700(5) |     |             |          — |
|                            |     | Market Value of Stock Vesting(10) |     |                  | — |     |                 | 278,505(7) |     |                  | 1,527,728(8) |     |             | 278,505(9) |
|                            |     | Total                             |     |                  | — |     |                 |  1,057,890 |     |                  |    2,307,113 |     |             |    278,505 |

| (1) | Represents 12 monthly payments of each executive’s monthly base salary from the time of termination. |

| (2) | Represents 24 monthly payments of executive’s monthly base salary from the time of termination. |

| (3) | Represents a lump sum payment equal to each executive’s target annual cash incentive bonus. |

| (4) | Represents a lump sum payment equal to two years of executive’s target annual cash incentive bonus. |

71

#### (5)Represents the cost of continued health and dental benefits. These benefits are payable until 12 months following